XENPOZYME 4 mg/1.1mL
olipudase alfa-rpcp · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Genzyme Corporation
XENPOZYME is a injection, powder, lyophilized, for solution containing olipudase alfa-rpcp at 4 mg/1.1mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- XENPOZYME
- Generic Name
- olipudase alfa-rpcp
- NDC Code (Product)
58468-0051- Manufacturer
- Genzyme Corporation
- Strength
- 4 mg/1.1mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761261
- Marketing Start
- 08/29/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is XENPOZYME used for?
XENPOZYME contains olipudase alfa-rpcp. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is XENPOZYME a controlled substance?
XENPOZYME is not classified as a controlled substance by the DEA.
What is the generic name for XENPOZYME?
The generic name for XENPOZYME is olipudase alfa-rpcp. There are no other listed brand versions of olipudase alfa-rpcp.
What is the NDC code for XENPOZYME 4 mg/1.1mL?
The NDC (National Drug Code) for XENPOZYME 4 mg/1.1mL is 58468-0051, listed by Genzyme Corporation.
Other XENPOZYME Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)